ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding ProPhase Labs, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 37 | 33 | −4 |
| Shares | 4.99M | 2.68M | −2.32M (−46.4%) |
| Value | $2.02M | $1.05M | −$969.7K (−48.1%) |
New holders (8)
Institutions that held ProPhase Labs, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sykon Capital LLC | 644,795 | $252.3K | 0.09% |
| XTX Topco Ltd | 102,506 | $40.1K | 0.00% |
| Citigroup Inc | 59,468 | $23.3K | 0.00% |
| Virtu Financial LLC | 40,401 | $16.0K | 0.00% |
| BKD Wealth Advisors, LLC | 19,598 | $7.67K | 0.00% |
| Cubist Systematic Strategies, LLC | 11,767 | $4.60K | 0.00% |
| Principal Securities, Inc. | 10,000 | $3.91K | 0.00% |
| Raymond James Financial Inc | 198 | $77 | 0.00% |
Sold out (12)
Institutions that held ProPhase Labs, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Wexford Capital LP | 1,525,611 | $616.8K |
| FourWorld Capital Management LLC | 376,577 | $152.3K |
| Citizens Financial Group Inc | 270,400 | $109.3K |
| Josh Arnold Investment Consultant, LLC | 250,000 | $100.0K |
| Sheets Smith Wealth Management | 208,300 | $84.2K |
| Perritt Capital Management Inc | 150,000 | $60.6K |
| Jane Street Group, LLC | 48,388 | $19.6K |
| Boston Private Wealth LLC | 47,665 | $19.3K |
| JustInvest LLC | 32,418 | $13.1K |
| Ritholtz Wealth Management | 10,000 | $4.04K |
| Nordwand Advisors, LLC | 10,000 | $4.04K |
| Advisor Group Holdings, Inc. | 2,000 | $809 |